###begin article-title 0
Ste20-Related Proline/Alanine-Rich Kinase (SPAK) Regulated Transcriptionally by Hyperosmolarity Is Involved in Intestinal Barrier Function
###end article-title 0
###begin p 1
Conceived and designed the experiments: YY SVS DM. Performed the experiments: YY GD. Analyzed the data: YY GD HTTN TSO DM. Contributed reagents/materials/analysis tools: YY GD HTTN TSO DM. Wrote the paper: YY DM.
###end p 1
###begin p 2
###xml 897 904 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 909 917 893 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1219 1227 1203 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1232 1239 1216 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 1148 1163 <span type="species:ncbi:10090">transgenic mice</span>
The Ste20-related protein proline/alanine-rich kinase (SPAK) plays important roles in cellular functions such as cell differentiation and regulation of chloride transport, but its roles in pathogenesis of intestinal inflammation remain largely unknown. Here we report significantly increased SPAK expression levels in hyperosmotic environments, such as mucosal biopsy samples from patients with Crohn's disease, as well as colon tissues of C57BL/6 mice and Caco2-BBE cells treated with hyperosmotic medium. NF-kappaB and Sp1-binding sites in the SPAK TATA-less promoter are essential for SPAK mRNA transcription. Hyperosmolarity increases the ability of NF-kappaB and Sp1 to bind to their binding sites. Knock-down of either NF-kappaB or Sp1 by siRNA reduces the hyperosmolarity-induced SPAK expression levels. Furthermore, expression of NF-kappaB, but not Sp1, was upregulated by hyperosmolarity in vivo and in vitro. Nuclear run-on assays showed that hyperosmolarity increases SPAK expression levels at the transcriptional level, without affecting SPAK mRNA stability. Knockdown of SPAK expression by siRNA or overexpression of SPAK in cells and transgenic mice shows that SPAK is involved in intestinal permeability in vitro and in vivo. Together, our data suggest that SPAK, the transcription of which is regulated by hyperosmolarity, plays an important role in epithelial barrier function.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 304 307 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Schilli1">[1]</xref>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Katz1">[2]</xref>
###xml 314 317 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Sandle1">[3]</xref>
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Vernia1">[4]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Cheromcha1">[5]</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li1">[6]</xref>
###xml 741 744 741 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Shapiro1">[7]</xref>
###xml 746 749 746 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 751 754 751 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Loitsch1">[9]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Asakawa1">[11]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hubert1">[12]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li2">[13]</xref>
###xml 823 827 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li2">[13]</xref>
###xml 888 892 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Ochi1">[14]</xref>
###xml 935 939 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Abolhassani1">[15]</xref>
###xml 1005 1009 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hubert1">[12]</xref>
###xml 1011 1015 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo1">[16]</xref>
###xml 1297 1300 1293 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Shapiro1">[7]</xref>
###xml 1335 1338 1331 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 1340 1343 1336 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Loitsch1">[9]</xref>
###xml 1371 1375 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Katsuyama1">[17]</xref>
###xml 1572 1575 1568 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Schilli1">[1]</xref>
###xml 1577 1580 1573 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Katz1">[2]</xref>
###xml 1582 1585 1578 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Sandle1">[3]</xref>
###xml 1587 1590 1583 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Vernia1">[4]</xref>
###xml 1592 1595 1588 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Cheromcha1">[5]</xref>
###xml 1302 1307 <span type="species:ncbi:9606">human</span>
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are multi-factorial diseases typically associated with relapsing diarrhea, which is caused by increased paracellular permeability of the intestinal epithelial lining and an intestinal hyperosmotic environment [1], [2], [3], [4], [5]. Intestinal epithelial cells (IECs) are exposed to the second most extreme osmotic environment after kidney. In many forms of IBD, including CD, neonatal necrotizing enterocolitis and UC, this extreme hyperosmolarity contributes to the exacerbation of intestinal inflammation via upregulation of inflammatory molecules such as matrix metalloproteinase (MMP)-9 [6], epithelial cytokine response-interleukin (IL)-8 [7], [8], [9], [10], IL-1 [11], [12], [13], and tumor necrosis factor (TNF)-alpha [13], downregulation of vascular cell adhesion molecule (VCAM)-1 [14], or methylation of protein phosphatase 2A [15]. Thus, hyperosmolarity is recognized as a proinflammatory signal [12], [16] in addition to classic inflammatory signals including bacteria, bacterial byproducts or proinflammatory cytokines. In addition to IECs, osmotic stress presents an important challenge to normal cell function in a variety of other cells, including peripheral blood mononuclear cells [7], human bronchial epithelial cells [8], [9] and the corneal epithelium [17]. Hyperosmolarity has been proposed to play a role in intestinal inflammation in several inflammatory bowel diseases, including CD and UC, as well as newborn and neonatal necrotizing enterocolitis [1], [2], [3], [4], [5].
###end p 4
###begin p 5
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Bagrodia1">[18]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Kyriakis1">[19]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Widmann1">[20]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Ip1">[21]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Klipp1">[22]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Endo1">[23]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Wagner1">[24]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Stockton1">[25]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Stockton2">[26]</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast ste20 kinases, and the mammalian homologs p21-activated kinase (PAK) and germinal center kinase (GCK), function as mitogen-activated protein kinase kinase kinase kinases (MAP4K) and have central and well-described roles in "cell-volume sensing" and in regulating a wide variety of gene functions, including barrier-related functions [18], [19], [20], [21], [22]. Lymphocyte-oriented kinase (LOK, ste20-like kinase) [23] and Ste20-like kinase (SLK) [24] can regulate actin cytoskeleton reorganization during cell adhesion and spreading, whereas PAK increases endothelial permeability [25], [26].
###end p 5
###begin p 6
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Johnston1">[27]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan1">[28]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Johnston1">[27]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Dan1">[30]</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li3">[31]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Piechotta1">[32]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Dowd1">[33]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Gagnon1">[34]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 646 647 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Topper1">[35]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nguyen1">[36]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Gamba1">[37]</xref>
###xml 913 917 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
The ste20-like proline/alanine-rich kinase (SPAK) belongs to the GCK IV subfamily, members of which contain an N-terminal series of proline and alanine repeats (PAPA box), followed by a catalytic domain, a nuclear localization signal, a consensus caspase-cleavage motif, and a C-terminal regulatory region [27], with the missing PAPA box and F-alpha helix loop present in its colonic isoform [28], [29]. SPAK plays roles in cell differentiation [27], [30], cell transformation and proliferation [31], regulation of chloride transport [32], [33], [34], and mediation of intestinal inflammation [29]. Specifically, SPAK can phosphorylate Na+-K+-2Cl- cotransporter 1 (NKCC1), which has an important role in inflammation [35], [36] and maintaining intracellular and extracellular ion homeostasis [37]. Recently, we have demonstrated that under inflammatory conditions, TNF-alpha is a key regulator of SPAK expression [29].
###end p 6
###begin p 7
The relationships among hyperosmolarity, SPAK and IBD are unknown. A better knowledge of these relationships will further our understanding of IBD physiopathology. The present study was therefore undertaken to determine how SPAK expression is regulated by hyperosmolarity and investigate its involvement in epithelial barrier function loss, which occurs during IBD.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Colonic SPAK is upregulated in patients with CD
###end title 9
###begin p 10
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g001">Fig. 1A</xref>
###xml 599 613 599 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g001">Fig. 1B and 1C</xref>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
As a preliminary step in a functional study of SPAK in IBD, it is sensible to study its expression profile. We examined SPAK expression in colonic biopsy samples from healthy and CD patients. Immunofluorescence of biopsy specimens from CD patients showed increased colonic SPAK expression, mainly in epithelial cells, compared with specimens of healthy colon tissue (Fig. 1A). Real-time PCR and Western-blot analyses showed that colonic mucosa from the same CD patients contained significantly increased SPAK expression at both the mRNA and protein levels compared with tissue from normal subjects (Fig. 1B and 1C).
###end p 10
###begin title 11
###xml 45 53 <span type="species:ncbi:9606">patients</span>
SPAK expression profile in colon tissue from patients with ulcerative colitis.
###end title 11
###begin p 12
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 80 87 <span type="species:ncbi:9606">patient</span>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 301 308 <span type="species:ncbi:9606">patient</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
###xml 460 467 <span type="species:ncbi:9606">patient</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
A. Immunostaining of SPAK in normal human colon tissue and Crohn's disease (CD) patient colon tissue from mucosal biopsies. SPAK expression (red); nuclear staining by DAPI (blue); SPAK is primarily expressed in epithelial cells. B. The expression of SPAK mRNA in normal human and Crohn's disease (CD) patient colon tissues from mucosal biopsies were quantified by real-time PCR, ** p<0.01. C. 30 mug of protein from normal human colon and Crohn's disease (CD) patient colon from mucosal biopsies were examined by western blot with SPAK antibody, colon tissue from CD patients demonstrated significantly higher levels of SPAK expression (upper part) vs. healthy colon, with GAPDH as the internal loading control.
###end p 12
###begin title 13
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Expression of SPAK is enhanced in colon tissue from hyperosmolarity treated mice
###end title 13
###begin p 14
###xml 295 302 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">Fig. 2A</xref>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g001">Fig. 1A</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">2A</xref>
###xml 603 610 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">Fig. 2B</xref>
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">Fig. 2C</xref>
###xml 760 767 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">Fig. 2A</xref>
###xml 943 950 943 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g002">Fig. 2B</xref>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
Next we examined the relative SPAK expression levels in colon samples from healthy mice and mice exposed to hyperosmotic conditions. Immunofluorescence analysis showed increased levels of colonic SPAK expression, mainly in epithelial cells, compared with sections from untreated colonic tissue (Fig. 2A). As shown in Fig. 1A and 2A, hyperosmolarity induces cell-wall damage and tissue shrinkage, and increases the space between crypts. Epithelial damage is apparent as early as 1 day after exposure to hyperosmolarity and progressively increases to a maximum level at day 5. Correspondingly, SPAK mRNA (Fig. 2B) and protein (Fig. 2C) levels in colonic tissue increase under hyperosmotic conditions and correlate with the extent and duration of colonic injury (Fig. 2A). The greatest increases in SPAK expression levels were on days 3 and 5; SPAK transcripts were detected at approximately 2.7-fold greater levels compared with untreated mice (Fig. 2B), as shown by real-time PCR, immunohistochemistry and Western-blot analyses. Together, these results indicate a strong correlation between SPAK expression level and the extent of hyperosmolarity.
###end p 14
###begin title 15
###xml 45 49 <span type="species:ncbi:10090">mice</span>
SPAK expression profile in colon tissue from mice treated with hyperosmolarity.
###end title 15
###begin p 16
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
A. Immunostaining of SPAK in colon sections of mice treated with hyperosmolarity at 0, 1, 3, and 5 days. SPAK (red); nuclear staining by DAPI (blue). B. Real time PCR analysis of SPAK mRNA expression in mucosa from colon tissue of hyperosmolarity treated mice. ** p<0.01. C. Western blot analysis of SPAK (upper part) expression in mucosa from colon tissue of hyperosmolarity treated mice, with GAPDH as the internal loading control.
###end p 16
###begin title 17
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Hyperosmolarity increases SPAK expression in intestinal epithelial cell lines in vitro
###end title 17
###begin p 18
###xml 391 398 391 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g003">Fig. 3A</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hallows1">[38]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Rizoli1">[39]</xref>
###xml 849 856 849 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g003">Fig. 3A</xref>
###xml 980 998 980 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g003">Fig. 3B, 3C and 3D</xref>
###xml 1284 1291 1284 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g003">Fig. 3E</xref>
Actin plays an important role in cell shape, volume and regulation of barrier function through interaction with tight-junction proteins; hence we examined the effects of hyperosmolarity on distribution of actin and expression levels of SPAK. We found that hyperosmolarity treatment leads to increased levels of Triton x-100-insolube F-actin and an increased ratio of F-actin versus G-actin (Fig. 3A). The newly polymerized F-actin predominantly localizes to the plasma membrane, where it forms a thick ring [38], [39] that persists as long as hyperosmolarity is maintained. Furthermore, immunofluorescence showed that hyperosmotic treatment leads to Caco2-BBE cell shrinkage and increases the intercellular space. Importantly, hyperosmotic conditions significantly increased SPAK expression levels and recruitment of SPAK to the membranes of cells (Fig. 3A). SPAK mRNA and protein levels were also increased, reaching maximum level as early as 3 min after hyperosmotic treatment (Fig. 3B, 3C and 3D). Here, we cannot conclude whether the high SPAK level was due to new synthesis or recruitment of SPAK to the membrane, or both. Under hyperosmotic conditions, SPAK levels increase in Triton x-100-soluble and insoluble pool, indicating SPAK recruitment to the F-actin-associated pool (Fig. 3E). Together, these data show that, under hyperosmotic conditions, increased SPAK is redistributed to actin-containing regions of the plasma membrane.
###end p 18
###begin title 19
SPAK expression in hyperosmolarity treated Caco2-BBE cells.
###end title 19
###begin p 20
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v.s.</italic>
A. Graph of ratio of triton x-100 insoluble actin v.s. soluble actin and western blot. B. Immunostaining of SPAK in colonic Caco2-BBE cells treated with hyperosmolarity at 0 and 15 min. SPAK (green); actin by rhodamine (red). (C) Real time PCR and (D) Western blot demonstrated that treatment of hyperosmolarity increases SPAK expression with GAPDH as internal loading control, ** p<0.01, *** p<0.001. E. Western blot showed that SPAK expression is increased by hyperosmolarity and is recruited to the triton-100 insoluble pool at 0, 1, 3, 8, 15 and 30 min.
###end p 20
###begin title 21
Induction of SPAK is primarily at the transcriptional level
###end title 21
###begin p 22
###xml 175 182 175 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g004">Fig. 4A</xref>
To determine whether the induction of SPAK expression under hyperosmotic conditions was mediated by transcriptional or post-transcriptional mechanisms, nuclear run-on assays (Fig. 4A) were performed in Caco2-BBE cells pretreated with or without hyperosmotic conditions. Compared with nuclei not exposed to hyperosmotic conditions, exposure to hyperosmotic conditions increased SPAK mRNA levels. This experiment was repeated three times and similar results were obtained each time. These results indicate that this increase in SPAK levels is due to increased transcription.
###end p 22
###begin title 23
Hyperosmolarity regulates SPAK expression at the transcriptional level.
###end title 23
###begin p 24
A. Nuclear run-on assay indicated the increase of SPAK mRNA transcription under the treatment of hyperosmolarity, with the mRNA transcription of GAPDH as internal control. B. Hyperosmolarity does not change SPAK mRNA stability; the percentage of remaining SPAK mRNA is shown at the different time point. Solid circle represents the value of real time PCR with the samples from Caco2-BBE cells without treatment, open circle represents the value of real time PCR with the samples from Caco2-BBE treated with actinomycin D, solid triangle represents real time PCR with the samples from Caco2-BBE treated with actinomycin D and hyperosmolarity. C. Northern blot analysis of total RNA from Caco2-BBE cells, Lane 1, no treatment, Lane 2, AcD, Lane 3, hyperosmolarity, and Lane 4, AcD and hyperosmolarity. The lower RNA electrophesis shows equal loading of each condition.
###end p 24
###begin title 25
The increase of SPAK transcription by hyperosmolarity is not mediated by alteration of mRNA stability
###end title 25
###begin p 26
###xml 791 798 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g004">Fig. 4B</xref>
###xml 970 977 967 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g004">Fig. 4C</xref>
###xml 1042 1049 1039 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g004">Fig. 4C</xref>
###xml 1099 1106 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g004">Fig. 4C</xref>
Changes in steady-state mRNA levels may be due to changes in the degradation rate of a transcript and/or rate of gene transcription. Hence, it was important to investigate the relative contribution of post-transcriptional mechanisms in the modulation of SPAK mRNA levels by hyperosmolarity. To assess SPAK mRNA stability, Caco2-BBE cells were treated with 5 mug/ml of AcD to inhibit mRNA synthesis, and SPAK mRNA levels were measured at the indicated time points in the presence and absence of hyperosmolarity by real-time RT-PCR; 18S rRNA was used as an internal control to normalize SPAK mRNA levels. The decay rate of SPAK mRNA in AcD-treated Caco2-BBE cells was almost the same as that of SPAK mRNA in cells treated with AcD plus hyperosmolarity; no significant difference was detected (Fig. 4B). In parallel, Northern-blot analyses were performed on 20-mug samples of Caco2-BBE mRNA treated with or without AcD (5 mug/ml) and/or exposed to hyperosmotic conditions (Fig. 4C). Results showed that AcD can significantly reduce mRNA levels (Fig. 4C lane 2) compared with untreated Caco2-BBE cells (Fig. 4C lane 1). In addition, hyperosmolarity treatment (in the absence of AcD treatment) markedly increased levels of SPAK mRNA transcripts. However, if Caco2-BBE cells were pretreated with AcD for 1 hour, hyperosmolarity cannot reverse the AcD-induced mRNA degradation. Together, these findings indicate that the observed changes in SPAK protein level are due to increased SPAK mRNA transcription rather than changes in mRNA stability.
###end p 26
###begin title 27
Sp1- and NF-kappaB-binding sites have roles in SPAK promoter activity
###end title 27
###begin p 28
###xml 916 930 892 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g005">Fig. 5A and 5B</xref>
###xml 1677 1684 1617 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g005">Fig. 5B</xref>
###xml 1861 1868 1797 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g005">Fig. 5C</xref>
###xml 2163 2177 2099 2113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g005">Fig. 5C and 5D</xref>
###xml 2403 2410 2323 2330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g005">Fig. 5D</xref>
###xml 197 202 <span type="species:ncbi:9606">human</span>
Having demonstrated that hyperosmolarity-induced SPAK expression is regulated at the transcriptional level, we cloned a approximately1.5-kb fragment of the 5'-flanking region of the SPAK gene from human genomic DNA to further understand the molecular mechanisms underlying the increased expression of SPAK. To identify the core promoter region of the SPAK gene, we generated five partial deletion constructs fused with the luciferase reporter gene. Caco2-BBE cells were transiently transfected with these constructs, then stimulated by exposure to hyperosmotic conditions (610 mOsm) for 30 min. Transcriptional activities were then measured using the Dual-Luciferase Reporter Assay System (Promega, San Luis, CA). The full-length promoter displayed increases of approximately18-fold in basal promoter activity and 74-fold in hyperosmolarity-stimulated promoter activities, compared with the empty pGL3 basic vector (Fig. 5A and 5B). Constructs I, II, III, IV and V had approximately16, 9, 10, 6 and 1-fold greater promoter activities, respectively, compared with the pGL3 vector at the basal level. Under hyperosmotic conditions, constructs I and II showed approximately70 and 53-fold increases, respectively, in promoter activity compared with the basic vector pGL3, to give activities that were about 95% and 72%, respectively, of the activity of the full-length SPAK promoter. The basal and hyperosmolarity-induced promoter activities of constructs III, IV and V were greater than those of the pGL3 vector (approximately26, 20, 4-fold increases, respectively); however, the activities were only about 35%, 27% and 6%, respectively, of that of the full-length SPAK promoter (Fig. 5B). To investigate and confirm the functional roles of the relevant binding motifs in regulating SPAK promoter activity, we generated various Sp1- and NF-kappaB-binding mutants (Fig. 5C). Using the transcriptional activity assay, we found that all the Sp1 mutants had significantly reduced basal promoter activities compared with the wild-type promoter, and the hyperosmolarity-stimulated activity levels of these Sp1 mutants were also lower than the wild-type promoter activity (Fig. 5C and 5D). By contrast, although the NF-kappaB mutant basal luciferase activity was similar to that of the wild-type promoter, there was a marked reduction in hyperosmolarity-stimulated promoter activity (approximately50% reduction) (Fig. 5D). Taken together, these results show that the Sp1-binding sites are important in basal and stimulated SPAK promoter activities, and that the NF-kappaB-binding site has a crucial role in hyperosmolarity-stimulation of SPAK promoter activities.
###end p 28
###begin title 29
Characterization of SPAK promoter.
###end title 29
###begin p 30
###xml 687 694 683 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 729 732 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
A. Schematic representation of human SPAK promoter constructs. the full-length SPAK promoter (nt-1472 to +4); construct I (nt -1050 to +4); construct II (nt -398 to +4); construct III (nt -331 to +4); construct IV (nt -149 to +4) and construct V (nt -72 to +4). Numbers are given in relation to the translational start codon (+1) and indicate 5'-ends of the deletion constructs. The location of the identified positive regulatory region is indicated by a light blue box. Positions of the putative Sp1 (Red) and NF-kappaB (Yellow) sites are indicated by arrows. B. Promoter activities of the 5' deleted constructs in un-treated or hyperosmolarity-stimulated Caco2-BBE cells normalized to Renilla Luc activities driven by the phRL-CMV control vector. Activities are expressed as fold inductions over cells transfected with the empty pGL3-basic vector. Each value represents the mean+/-SD of at least 3 independent sets of transfection experiments performed in triplicate, *p<0.05; **p<0.01. C. Schematic representation of mutated SPAK promoter constructs: the full-length SPAK promoter; I Sp1 binding site (-496); II Sp1 binding site (-303); III Sp1 binding site (-114) and NF-kappaB binding site (-354). The digits are given in relation to the translational start codon (+1). The location of the identified positive regulatory region is indicated by a light blue box. Positions of the putative Sp1 sites are indicated by arrows and NF-kappaB is indicated by rectangle. The corresponding mutated transcription factor binding site is indicated by black arrow or black rectangle. D. Effects of mutations of Sp1 or NF-kappaB binding sites on SPAK promoter activity. The various mutated constructs were transiently transfected into Caco2-BBE cells under the basal (gray bar) or hyperosmolarity conditions. Promoter activity of the full-length wild-type construct was set to 100% (control). Values represent means+/-SD of at least 3 independent sets of transfection experiments performed in triplicate, *p<0.05, **p<0.01.
###end p 30
###begin title 31
Sp1 and NF-kappaB are physically associated with their corresponding binding sites
###end title 31
###begin p 32
###xml 334 341 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6A</xref>
###xml 354 361 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6B</xref>
###xml 374 381 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6C</xref>
###xml 404 411 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6D</xref>
###xml 623 645 607 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6A, 6B, 6C and 6D</xref>
###xml 807 825 791 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6A, 6B and 6C</xref>
###xml 959 966 943 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6C</xref>
###xml 1082 1089 1062 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1246 1253 1222 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g006">Fig. 6E</xref>
To study the association between the transcription factors and the corresponding binding sequences, and to further confirm the importance of Sp1 and NF-kappaB in activation of the SPAK gene, we used electrophoretic mobility shift assays (EMSA) to characterize binding of Sp1 and NF-kappaB to their respective binding sites: Sp1 -496 (Fig. 6A), Sp1 -303 (Fig. 6B), Sp1 -114 (Fig. 6C), and NF-kappaB -354 (Fig. 6D). EMSA revealed that incubation of the DNA-protein complexes with anti-Sp1 or anti-p65 antibodies shifted the migrating bands in an upward direction, indicating specificity for Sp1 and NF-kappaB (p65) proteins (Fig. 6A, 6B, 6C and 6D, lane 4). Exposure to hyperosmotic conditions for 30 min increased the binding of Sp1 to the corresponding oligonucleotides compared with the untreated control (Fig. 6A, 6B and 6C, lane 3). This indicates that hyperosmolarity increases Sp1 expression or binding of Sp1 to oligonucleotides. Similarly, as shown in Fig. 6C, hyperosmolarity treatment increases NF-kappaB (p65) binding to the corresponding oligonucleotides. To confirm the in vivo importance of Sp1 and NF-kappaB (p65) binding sites in response to hyperosmolarity, we performed chromatin immunoprecipitation (ChIP) analyses. As shown in Fig. 6E, under resting conditions, Sp1 binds to the I Sp1 (lane 1), II Sp1 (lane 3), and III Sp1 (lane 5) binding sites and NF-kappaB (p65) binds to the NF-kappaB-binding site (lane 7). Hyperosmolarity treatment increases the DNA-binding activities of Sp1 and NF-kappaB (p65) to their binding sites. Together, these results indicate that Sp1 and NF-kappaB binding increases under hyperosmotic conditions. These data, together with the results of the promoter studies, demonstrate the critical role of Sp1 and NF-kappaB in the regulation of basal and hyperosmolarity-induced SPAK expression.
###end p 32
###begin title 33
EMSA of (A) I Sp1 (-496), (B) II Sp1 (-303), (C) III Sp1 (-114), (D) NF-kappaB (-354).
###end title 33
###begin p 34
Lane 1, biotin-labeled oligonucleotide alone; lane 2, biotin-labeled oligonucleotides incubated with 5 mug Caco2-BBE nuclear extracts; lane 3, biotin-labeled oligonucleotides incubated with 5 mug hyperosmolarity-treated Caco2-BBE nuclear extracts; lane 4, biotin-labeled oligonucleotides incubated with 5 mug Caco2-BBE nuclear extracts in the presence of anti-Sp1 (A-C) or NF-kB (p65) (D) antibodies; lane 5, biotin-labeled oligonucleotides incubated with 5 mug Caco2-BBE nuclear extracts in the presence of non-specific IgG; lane 6, biotin-labeled oligonucleotides incubated with 5 mug Caco2-BBE nuclear extracts in the presence of a 50-fold excess of cold competitor oligonucleotide; lane 7, biotin-labeled binding site-mutated oligonucleotides incubated with 5 mug Caco2-BBE nuclear extracts. E. Chromatin immunoprecipitation (ChIP) assay: the antibodies indicated were incubated with cross-linked DNA isolated from Caco2-BBE cells treated with (+) or without (-) hyperosmolarity, IgG antisera acts as control. Sp1 (I, II, and III) and NF-kappaB promoter elements in the immunoprecipitates were detected by PCR. The lower panel shows DNA input as template for internal control.
###end p 34
###begin title 35
###xml 77 84 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Hyperosmolarity increases SPAK expression via increased NF-kappaB expression in vivo
###end title 35
###begin p 36
###xml 261 268 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g007">Fig. 7A</xref>
###xml 465 472 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 782 789 770 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g007">Fig. 7B</xref>
###xml 904 911 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 916 924 900 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
To confirm the effects of hyperosmolarity on SPAK expression, nuclear proteins were extracted from colonic epithelial cells of mice treated exposed to hyperosmotic conditions and subjected to Western-blot analysis with Sp1 and NF-kappaB antibodies. As shown in Fig. 7A, after different durations of hyperosmolarity exposure, there was no significant change in the Sp1 protein level; however, expression of NF-kappaB (p65) increased as early as the first day. These in vivo data show that hyperosmolarity does not affect the overall nuclear levels of Sp1; however, hyperosmolarity treatment induces translocation of NF-kappaB (p65) to the nucleus and upregulates its expression level. These results were confirmed with Caco2-BBE cells exposed to hyperosmotic conditions. As shown in Fig. 7B, hyperosmotic medium significantly increases NF-kappaB (p65) expression levels, but not Sp1 levels. Together, the in vivo and in vitro studies demonstrate that hyperosmolarity regulates SPAK in a NF-kappaB-dependent manner.
###end p 36
###begin title 37
Western blots of transcription factors Sp1 and NF-kappaB (p65).
###end title 37
###begin p 38
###xml 117 124 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 271 279 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 581 602 557 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
A. Western blots of Sp1 and NF-kappaB (p65) demonstrating hyperosmolarity effect on Sp1 and NF-kappaB protein levels in vivo. Histone3 acts as a control. B. Western blots of Sp1 and NF-kappaB (p65) demonstrating hyperosmolarity effect on Sp1 and NF-kappaB protein levels in vitro. Histone3 acts as a control. C. Reduction of NF-kappaB but not Sp1 expression reduced SPAK protein expression in unstimulated and in hyperosmolarity-stimulated Caco2-BBE cells. Cells were harvested and subjected to western blot analysis using Sp1, NF-kappaB (p65), and SPAK antibodies as described in materials and methods. GAPDH acts as a loading control.
###end p 38
###begin title 39
Reduction of Sp1 or NF-kappaB expression differentially regulates SPAK expression
###end title 39
###begin p 40
###xml 221 228 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g007">Fig. 7C</xref>
###xml 982 989 958 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g007">Fig. 7C</xref>
One approach to studying the functional role of a specific protein is to knockdown its expression. To further study SPAK regulation by Sp1 and NF-kappaB, we used siRNA to prevent Sp1 and NF-kappaB expression. As shown in Fig. 7C, Caco2-BBE cells transfected with siRNA against Sp1 and NF-kappaB (p65) showed decreased expression levels of Sp1 (lanes 1 and 2) and NF-kappaB (p65) (lanes 5 and 6) compared with Caco2-BBE cells transfected with scrambled control siRNA. Basal SPAK protein expression was also significantly reduced in Caco2-BBE cells transfected with Sp1-specific siRNA (SPAK lane 1 vs lane 4); however, there were no significant reductions in SPAK expression in cells transfected with NF-kappaB (p65)-specific siRNA (SPAK lane 5 vs lane 8). Thus, basal SPAK expression is effectively reduced by reduced levels of Sp1. We further investigated whether siRNA against Sp1 and/or against NF-kappaB reduced the levels of hyperosmolarity-induced SPAK expression. As shown in Fig. 7C, hyperosmolarity-induced SPAK expression levels were significantly reduced in Caco2-BBE cells transfected with Sp1-specific siRNA or NF-kappaB-specific siRNA (SPAK lanes 2 and 6, respectively) compared with cells transfected with scrambled siRNA (SPAK lane 3 and 7). These data demonstrate that Sp1 has an important role in the basal expression of SPAK, and Sp1 and NF-kappaB have important roles in the transcriptional regulation of SPAK expression under hyperosmotic conditions.
###end p 40
###begin title 41
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
SPAK expression regulates epithelial barrier function in vitro
###end title 41
###begin p 42
###xml 360 374 360 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g008">Fig. 8A and 8B</xref>
###xml 397 418 397 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Materials and Methods</italic>
###xml 397 418 397 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>Materials and Methods</italic></xref>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g008">Fig. 8A</xref>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
On the basis of our data showing that SPAK expression is increased in colonic tissue of CD patients, we hypothesized that SPAK may play a role in epithelial barrier function. We studied permeability in Caco2-BBE cells stably transfected with SPAK/pcDNA6, vector pcDNA6, SPAK siRNA or Con siRNA using a fluorescein isothiocyanate (FITC)-labeled dextran method (Fig. 8A and 8B), as described in the Materials and Methods. Fluorescence was quantified in the lower chamber 2 hours after the administration of FITC-dextran. As shown in Fig. 8A, vector-transfected cells showed an FITC-dextran level of 12.1+/-2.6 ng of FITC/ml protein/min. In comparison, there was a approximately2-fold increase in FITC-dextran levels in SPAK/pcDNA6-transfected cells (23.8+/-4.03 ng of FITC/ml protein/min), almost no change in FITC-dextran levels in Con-siRNA-transfected cells (13.9+/-3.2 ng of FITC/ml protein/min), and a approximately3.2-fold decrease in FITC-dextran levels in SPAK-siRNA-transfected cells (4.3+/-1.3 ng of FITC/ml protein/min). These results indicate that overexpression of SPAK increases the permeability of cells and reduced SPAK expression decreases the permeability.
###end p 42
###begin title 43
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
SPAK is involved in epithelial barrier function in vitro.
###end title 43
###begin p 44
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 365 373 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A. In vitro permeability assay in Caco2-BBE cells transfected with pcDNA6, SPAK/pcDNA6, con siRNA or SPAK siRNA with 4 kDa FITC-Dextran. Fluorescence was quantified in lower chamber at 2 hours after the administration of FITC-dextran (lambda ex = 492 nm, lambda em = 510), *p<0.05, **p<0.01. B. Western blot of Caco2-BBE cells protein scraped from filter after the in vitro permeability assay.
###end p 44
###begin title 45
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
SPAK expression regulates epithelial barrier function in vivo
###end title 45
###begin p 46
###xml 250 256 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">villin</italic>
###xml 349 367 349 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g009">Fig. 9A, 9B and 9C</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Pinto1">[40]</xref>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 675 681 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">villin</italic>
###xml 864 885 864 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Materials and Methods</italic>
###xml 864 885 864 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>Materials and Methods</italic></xref>
###xml 1017 1024 1017 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005049-g009">Fig. 9D</xref>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 157 172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 789 804 <span type="species:ncbi:10090">transgenic mice</span>
###xml 887 891 <span type="species:ncbi:10090">Mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1115 1130 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1275 1279 <span type="species:ncbi:10090">mice</span>
Transgenic mice have been widely used as a robust, dependable animal model of human disease. To better understand the function of SPAK in IECs, we generated transgenic mice that expressed a constitutively active form of SPAK under the control of the villin gene locus control region (LCR), which can target SPAK expression only in IECs (as shown in Fig. 9A, 9B and 9C) at the mRNA and protein levels, as described previously [40]. Our data demonstrated that Caco2-BBE cells stably transfected with SPAK showed increased permeability in vitro, so it was important to study the role of SPAK in epithelial barrier function in mice. With SPAK transgenic FVB/6 mice harboring the villin gene, which limits SPAK overexpression in the intestine, we studied barrier function in wild-type and SPAK transgenic mice using the FITC-labeled dextran method, as described in the Materials and Methods. Mice were administered FITC-dextran by gavage, and fluorescence was quantified in the serum 4 h after administration. As shown in Fig. 9D, wild-type mice had a FITC-dextran level of 0.805+/-78 mg /mug protein. By contrast, SPAK transgenic mice showed a approximately4.5-fold increase in the FITC-dextran level (3.469+/-234 mg /mug protein), indicating decreased barrier function in these mice.
###end p 46
###begin title 47
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
SPAK is involved in epithelial barrier function in vivo.
###end title 47
###begin p 48
###xml 112 122 112 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsiw1/Mlu1</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal1</italic>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 481 496 <span type="species:ncbi:10090">transgenic mice</span>
###xml 517 532 <span type="species:ncbi:10090">transgenic mice</span>
A. Schematic diagram of villin/SPAK transgene construct, full length SPAK cDNA was cloned into villin vector by Bsiw1/Mlu1 sites; villin/SPAK was digested with Sal1 before microinjection. B. SPAK is tissue-specifically over-expressed in intestine by real time PCR with samples from small intestine, colon and liver. C. SPAK is specifically over-expressed in intestine by western blot with samples from small intestine, colon and liver. D. in vivo permeability assay in villin/SPAK transgenic mice, WT: wide type; TG: transgenic mice, ** p<0.01.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Schilli1">[1]</xref>
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Katz1">[2]</xref>
###xml 265 268 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Sandle1">[3]</xref>
###xml 384 387 384 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Schilli1">[1]</xref>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Vernia1">[4]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hirayama1">[41]</xref>
###xml 890 893 890 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 930 933 930 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Shapiro1">[7]</xref>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 1064 1068 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-ElSherbeny1">[42]</xref>
###xml 1126 1129 1126 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li1">[6]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-BaudouinLegros1">[43]</xref>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 781 786 <span type="species:ncbi:4932">yeast</span>
###xml 1095 1100 <span type="species:ncbi:9606">human</span>
In this study, we demonstrated for the first time that colonic SPAK expression levels are increased in mucosal biopsy samples of patients with CD. It is known that patients with CD have markedly higher colonic osmolarity compared with healthy individuals [1], [2], [3], and this high colonic osmolarity contributes to the activation of colonic mucosal inflammation in Crohn's colitis [1], [4]. This high osmolarity also led to increased expression of colonic SPAK in mice and a Caco2-BBE cell model, and the SPAK expression level was correlated with the extent of colonic mucosa injury. We can conclude that hyperosmolarity can upregulate the SPAK expression. Hyperosmolarity can also regulate the expression of other molecules; examples of such regulation include upregulation of yeast alpha-glycerophosphate dehydrogenase 1 (GPD1) [41], upregulation of IL-8 in bronchial epithelial cells [8], peripheral blood mononuclear cells [7] and the intestinal epithelial cell lines Caco2-BBE and HT29 [10], upregulation of the taurine transporter (TauT) in ARPE-19 cells [42], upregulation of MMP-9 in human corneal epithelial cells [6], and downregulation of the cystic fibrosis transmembrane conductance regulator (CFTR) in HT29 and T84 cells [43].
###end p 50
###begin p 51
###xml 574 578 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Briggs1">[44]</xref>
###xml 580 584 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Saffer1">[45]</xref>
###xml 613 617 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Jones1">[46]</xref>
###xml 918 922 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hayden1">[47]</xref>
###xml 924 928 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hoffmann1">[48]</xref>
###xml 1133 1137 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Kunsch1">[49]</xref>
###xml 1139 1143 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Ghosh1">[50]</xref>
###xml 1145 1149 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Zhang1">[51]</xref>
###xml 1246 1250 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Scheinman1">[52]</xref>
###xml 1252 1256 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Visekruna1">[53]</xref>
###xml 1393 1397 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Perkins1">[54]</xref>
###xml 1399 1403 1375 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-GomezGonzalo1">[55]</xref>
###xml 1405 1409 1381 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Sheppard1">[56]</xref>
###xml 1456 1460 1428 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Kerr1">[57]</xref>
###xml 1479 1483 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Jones1">[46]</xref>
###xml 1491 1495 1463 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Shu1">[58]</xref>
###xml 1497 1501 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Neish1">[59]</xref>
###xml 1669 1673 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Perkins1">[54]</xref>
###xml 1803 1807 1771 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Sanceau1">[60]</xref>
###xml 1809 1813 1777 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hirano1">[61]</xref>
###xml 1473 1478 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We used the SPAK TATA-less promoter to study the mechanisms underlying the hyperosmolarity-induced changes in SPAK expression during intestinal inflammation. We found that Sp1 binding sites are important both for basal and hyperosmolarity-induced promoter activities, whereas the NF-kappaB binding site plays an important role in the hyperosmolarity-induced promoter activity. Sp1 is known to support constitutive expression of a variety of eukaryotic genes that lack a functional TATA box and is thought to have key roles in regulating the expression of both house-keeping [44], [45] and non-house keeping genes [46]. NF-kB comprises a family of proteins that form a variety of hetero- and homodimers, the subunits of which upregulate gene transcription induced by inflammatory stimuli such as cytokines, bacterial products, viral expression, growth factors, and other stress stimuli in an NF-kappaB-dependent manner [47], [48]. Transcription of several genes is upregulated, including those encoding the proinflammatory cytokines IL-1, IL-6, IL-12, TNF-alpha, IFN-gamma and IL-8, the chemokine MIP-1 and the adhesion molecule ICAM [49], [50], [51]. NFkappaB has also been shown to be involved in the regulation of inflammatory responses in IBD [52], [53]. NFkappaB is known to function together with cooperating transcription factors and coactivators, such as Sp1, to activate transcription [54], [55], [56]. For example, NF-kappaB can interact with Sp1 [57] to regulate HIV-1 [46], ICAM1 [58], [59], and granulocyte macrophage colony-stimulating factor 1 (GM-CSF); the interaction involves the zinc finger region of Sp1 and the N-terminal Rel homology domain of p65 [54]. Under certain conditions, NF-kappaB can also bind to the consensus sequence of the Sp1 binding site, thereby competing with Sp1 [60], [61].
###end p 51
###begin p 52
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Lang1">[62]</xref>
###xml 266 270 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 272 276 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Abolhassani1">[15]</xref>
###xml 278 282 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hao1">[63]</xref>
###xml 755 759 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Scheinman1">[52]</xref>
###xml 761 765 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Auphan1">[64]</xref>
###xml 767 771 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Lenardo1">[65]</xref>
###xml 773 777 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Lenardo2">[66]</xref>
###xml 779 783 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Kopp1">[67]</xref>
###xml 1150 1154 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
We found that hyperosmolarity does not affect the overall nuclear levels of Sp1 in mice or Caco2-BBE cells, in agreement with previous results [62]. However, under hyperosmotic conditions the expression and translocation of NF-kappaB into the nucleus were increased [10], [15], [63], which indicates that increased expression of SPAK is, at least in part, due to increased expression of NF-kappaB as well as increased binding of Sp1 and NF-kappaB to their binding sites. Our data also show that knock-down of NF-kappaB (p65) or Sp1 by siRNA can significantly decrease SPAK expression levels, confirming their importance in the regulation of SPAK expression and indicating their potential as a target for the treatment of inflammatory diseases such as IBD [52], [64], [65], [66], [67]. Our results additionally demonstrate that NF-kappaB and Sp1 transcription factors are essential for regulation of SPAK expression under hyperosmotic conditions. However, SPAK expression may be regulated by multiple transcription factor pathways because we have previously reported that TNF-alpha-regulated SPAK expression is NF-kappaB-dependent but Sp1-independent [29].
###end p 52
###begin p 53
###xml 200 210 200 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-So1">[68]</xref>
###xml 460 464 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Carter1">[69]</xref>
###xml 696 700 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Bagnasco1">[70]</xref>
###xml 702 706 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Moriyama1">[71]</xref>
###xml 875 879 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-BaudouinLegros1">[43]</xref>
###xml 889 893 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-ElSherbeny1">[42]</xref>
###xml 982 985 974 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 987 991 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 200 210 <span type="species:ncbi:7227">Drosophila</span>
Nuclear run-on assays are commonly used to determine whether an increase in mRNA level is due to an increase in transcription, a decrease in the degradation rate, or both. For example, mRNA levels in Drosophila[68] were found to be regulated at a post-transcriptional level without evident transcriptional regulation; however, simultaneous inhibition of both Erk and p38 kinase pathways decreased the levels of cytokine gene transcription (IL-6 and TNF-alpha) [69]. Our data show that exposure to hyperosmotic conditions (for 60 min) significantly increases SPAK mRNA transcription, which is in agreement with previous reports that osmolarity does not affect mRNA stability or enzyme degradation [70], [71]. However, hyperosmolarity can regulate the expression of target genes by several different mechanisms; for example, the transcriptional decrease in mRNA levels of CFTR [43] and TauT [42], and induction of IL-8 through activation of NF-kappaB in a p38-kinase-dependent manner [8], [10].
###end p 53
###begin p 54
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+</sup></italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Schweigel1">[72]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Safdar1">[73]</xref>
###xml 397 406 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005049.s001">Figure S1</xref>
###xml 436 439 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li2">[13]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-BaudouinLegros1">[43]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Han1">[74]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo2">[75]</xref>
###xml 649 658 642 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005049.s002">Figure S2</xref>
###xml 726 730 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 732 736 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hubert1">[12]</xref>
###xml 738 742 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Li2">[13]</xref>
###xml 744 748 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo1">[16]</xref>
###xml 750 754 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Bruewer1">[76]</xref>
###xml 843 847 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo1">[16]</xref>
###xml 849 853 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo2">[75]</xref>
###xml 855 859 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Mosser1">[77]</xref>
###xml 978 987 971 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005049.s001">Figure S1</xref>
###xml 989 993 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Luo2">[75]</xref>
###xml 995 999 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yujiri1">[78]</xref>
###xml 1001 1005 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Duzgun1">[79]</xref>
###xml 1007 1011 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Galvez1">[80]</xref>
###xml 1083 1087 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Howe1">[81]</xref>
###xml 1247 1251 1240 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Dudek1">[82]</xref>
###xml 1253 1257 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Shasby1">[83]</xref>
###xml 1259 1263 1252 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Poli1">[84]</xref>
###xml 1419 1423 1412 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Omori1">[85]</xref>
###xml 1425 1429 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Ilic1">[86]</xref>
###xml 1554 1563 1547 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005049.s003">Figure S3</xref>
###xml 144 149 <span type="species:ncbi:9940">sheep</span>
Hyperosmolarity has multiple and complex cellular effects. For example, hyperosmolarity decreases Na+ transport and impairs barrier function of sheep rumen epithelium [72]; however, it increases the lung capillary barrier [73]. The mechanisms underlying the various aspects of barrier function affected by hyperosmolarity are complicated. First, hyperosmolarity activates the p38 and JNK pathway (Figure S1), as demonstrated previously [8], [10], [13], [43], [74], [75], which in turn can lead to increased epithelial permeability. Second, hyperosmolarity induces the production of proinflammatory cytokines such as TNF-alpha, IL-1beta, IL-6, IL-8 (Figure S2) that disrupt epithelial barrier function, as described previously [10], [12], [13], [16], [76]. Third, hyperosmolarity can induce apoptosis, resulting in the loss of barrier function [16], [75], [77]. However, in agreement with previous reports, in the present study hyperosmolarity also activated the Erk1/2 pathway (Figure S1) [75], [78], [79], [80], which is involved in the mechanism by which permeability is decreased [81]. Furthermore, hyperosmolarity leads to redistribution and polymerization of cortical F-actin, which is involved in the downregulation of cellular permeability [82], [83], [84]. Hyperosmolarity can induce activation of focal adhesion kinase and redistribution of focal adhesion protein, which can lead to increased barrier function [85], [86]. Finally, in the present study, hyperosmolarity (610 mOsm, 30 min) did not induce significant apoptosis in Caco2-BBE cells (Figure S3), which eliminates the possibility that this pathway increases epithelial permeability.
###end p 54
###begin p 55
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">villin</italic>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Pinto1">[40]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Goyette1">[87]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Dignass1">[88]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Clayburgh1">[89]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Johnston1">[27]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan1">[28]</xref>
###xml 986 989 986 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hashimoto1">[8]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nemeth1">[10]</xref>
###xml 997 1001 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Craxton1">[90]</xref>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Hollenbach1">[91]</xref>
###xml 1073 1077 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Saffer1">[45]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-ZenzieGregory1">[92]</xref>
###xml 1085 1089 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Zhang2">[93]</xref>
###xml 196 211 <span type="species:ncbi:10090">transgenic mice</span>
###xml 256 271 <span type="species:ncbi:10090">Transgenic mice</span>
Here we showed that upregulation of SPAK expression is directly involved in the regulation of intestinal barrier permeability. As demonstrated using the FITC-dextran method in Caco2-BBE cells and transgenic mice, SPAK can cause severe barrier dysfunction. Transgenic mice harboring the SPAK gene under control of the villin gene utilize the tissue-specific expression of villin in the intestinal epithelium, which facilitates transgenic SPAK expression in a tissue-specific manner [40] without causing unexpected results in other tissues. The barrier dysfunction caused by SPAK overexpression is important because it has a central role in the pathogenesis of intestinal inflammation [87], [88], [89]. Different mechanisms may underlie the SPAK-induced increase in transepithelial permeability, including activation of the p38 pathway [27], [28], which can increase epithelial permeability. A strong link has been established between the p38 pathway, cell volume change and inflammation [8], [10], [90], [91], as well as in the regulation of cell motility and wound healing [45], [92], [93].
###end p 55
###begin p 56
In conclusion, we report that during inflammatory diseases (such as IBD) and hyperosmotic conditions, the SPAK expression level was significantly upregulated at the transcriptional level due to multiple factors, including the transcription factors NF-kappaB and Sp1. Our data demonstrate that SPAK expression is upregulated by hyperosmolarity and is an important mediator of barrier function. SPAK expression may thus contribute to the pathogenesis of intestinal inflammatory diseases such as IBD.
###end p 56
###begin title 57
Materials and Methods
###end title 57
###begin title 58
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human material
###end title 58
###begin p 59
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 355 363 <span type="species:ncbi:9606">patients</span>
The diagnosis of IBD was based on clinical, endoscopic, and histological criteria. Clinical data for IBD patients were obtained by medical record review. Infectious colitis was ruled out by stool cultures. The collection of samples was approved by the Institutional Review Board of Emory University. Mucosal biopsy specimens from 4 Crohn's disease active patients were obtained during routine endoscopy that was performed after written informed consent was obtained. Control biopsy samples were collected from 6 volunteers undergoing colonoscopy for colorectal cancer screening who had no overt pathology including polyps. Biopsy specimens were snap frozen in Optimal Cutting Temperature immediately after endoscopic resection and stored at -80degreesC for histological immunostaining or homogenized to extract protein for western immunoblotting or RNA for real time PCR.
###end p 59
###begin title 60
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model
###end title 60
###begin p 61
###xml 639 640 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">Mice</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
C57BL/6 and FVB/6 mice (8 wk, 18-22 g) obtained from Jackson Laboratories (Bar Harbor, ME). Mice were group housed under a controlled temperature (25degreesC) and photoperiod (12:12-h light-dark cycle) and allowed unrestricted access to standard mouse chow and tap water. They were allowed to acclimate to these conditions for at least 7 days before inclusion in the experiments. All animal experiments were approved by The Institutional Animal Care and Use Committee of Emory University, Atlanta and were in accordance with the guide for the Care and Use of Laboratory Animal, published by the U.S. Public Health Service. Groups of mice (n = 6 mice/group) were treated with hyperosmotic medium (610 mOsm) prepared by dissolving mannitol (0.3 M) in phosphate buffered saline (PBS) for indicated days.
###end p 61
###begin title 62
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice
###end title 62
###begin p 63
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan1">[28]</xref>
###xml 106 116 106 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsiWI/MluI</italic>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Pinto1">[40]</xref>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">villin</italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">villin</italic>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SalI</italic>
###xml 668 694 668 694 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGCTGTGATAGCACACAGGA 3&#8242;</named-content>
###xml 708 734 708 734 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTGCCTGAACCACAGCAGTA 3&#8242;</named-content>
###xml 747 773 747 773 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGGGTTTGCTCAGTTGAGTG 3&#8242;</named-content>
###xml 787 813 787 813 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AGTCGACGAATTCCGATTTG 3&#8242;</named-content>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 143 147 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 426 431 <span type="species:ncbi:10090">Mouse</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
The full-length human colonic SPAK cDNA [28] spanning from nucleotide 139 to 1569 was introduced into the BsiWI/MluI site of pBS KS Villin MES SV40 polyA vector [40] harboring the villin gene, the villin promoter can target SPAK over expression in villin-containing intestine. The transgene SPAK digested with SalI were injected into the pronuclei of the fertilized eggs of the FVB/6 mice in collaboration with the Transgenic Mouse and Gene Targeting Core Facility (Emory University). Transgene-carrying mice were identified by PCR of genomic DNA extracted from mice tails with REDExtract-N-Amp Tissue PCR kit (Sigma-Aldrich, ST. Louis, MO). The primers were: Prim1F (5' GGCTGTGATAGCACACAGGA 3') and Prim1R (5' CTGCCTGAACCACAGCAGTA 3') or Prim2F (5' TGGGTTTGCTCAGTTGAGTG 3') and Prim2R (5' AGTCGACGAATTCCGATTTG 3'). Stable SPAK-transgenic lines were established by backcrossing transgene-carrying founder mice with FVB/6 mice (Jackson Laboratories, Bar Harbor, ME).
###end p 63
###begin title 64
Cell culture
###end title 64
###begin p 65
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human intestinal cell line Caco2-BBE was cultured according to the standard protocol. Caco2-BBE cells were treated with isosmolar medium or hyperosmotic mdium (610 mOsm) prepared by adding 0.3 M mannitol (Sigma-Aldrich, ST. Louis, MO) to regular Dulbecco's modified Eagle's medium DMEM (Invitrogen, Carlsbad, CA).
###end p 65
###begin title 66
Plasmids construction
###end title 66
###begin p 67
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
SPAK promoter, its different truncates and site-directed mutants were cloned and constructed in our lab previously [29].
###end p 67
###begin title 68
Western blot
###end title 68
###begin p 69
Western blot were carried out based on the standard methods with relevant antibodies.
###end p 69
###begin title 70
Immunohistochemistry
###end title 70
###begin p 71
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 198 204 <span type="species:ncbi:9986">rabbit</span>
###xml 253 259 <span type="species:ncbi:9986">rabbit</span>
Immunostaining was performed according to the standard protocol. Briefly, 7-mum cryostat sections of mouse colon were fixed in buffered 4% paraformaldehyde for 30 min, blocked specimen in 5% normal rabbit serum in PBS/Triton for 1 h, and incubated with rabbit SPAK antibody (Cell signalling technology Inc, Danvers, MA) overnight at 4degreesC, washed with phosphate-buffered saline (PBS), and subsequently incubated with fluoresceinated secondary antibody for 1 h at room temperature. Colon sections were stained with 4', 6-Diamidine-2'-phenylindole dihydrochloride (DAPI) to visualize nuclear.
###end p 71
###begin p 72
###xml 487 488 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 230 236 <span type="species:ncbi:9986">rabbit</span>
Caco2-BBE cells grown on filters were washed and fixed with 4% paraformaldehyde in PBS with calcium for 20 min. The cells were then permeabilized with 0.1% Triton/PBS for 30 min at room temperature. Monolayers were incubated with rabbit SPAK antibody and then with relevant fluoresceinated secondary antibody same as for colon cryostat sections. Subsequently, monolayers were stained with rhodamine/phalloidin (Molecular Probes, Carlsbad, CA) to visualize actin. Samples were mounted in p-phenylenediamine/glycerol (1:1) and analyzed by confocal microscopy (Zeiss dual-laser confocal microscope).
###end p 72
###begin title 73
Real time PCR
###end title 73
###begin p 74
###xml 511 540 502 531 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGGAATTAGCAACAGGAGCAGCG 3&#8242;</named-content>
###xml 552 581 543 572 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TTTCCAAAGTGGGTGGATCATTT 3&#8242;</named-content>
###xml 621 647 612 638 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; ACCACAGTCCATGCCATCAC 3&#8242;</named-content>
###xml 659 685 650 676 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TCCACCACCCTGTTGCTGTA 3&#8242;</named-content>
###xml 709 736 700 727 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GTAAGGCGAGTTCCTGGGTCG 3&#8242;</named-content>
###xml 748 775 739 766 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCAGTCGCCGTCTTCAGTCTT 3&#8242;</named-content>
###xml 813 837 804 828 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TCCAGGCTTTGGGCATCA 3&#8242;</named-content>
###xml 849 877 840 868 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTTTATCAGCTGCACATCACTCAGA</named-content>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
total RNA from Caco2-BBE cells, mucosa of mouse colon tissue and patients biopsy specimens were extracted with TRIzol reagent (Invitrogen, Carlsbad, CA), reverse transcribed using the Thermoscripttrade mark RT-PCR System (Invitrogen, Carlsbad, CA) and purified with the RNeasy Mini Kit (Qiagen, Germantown, MD). Real time PCRs were performed using iQ SYBR Green Supermix kit (Bio-Rad, Hercules, CA) with the iCycler sequence detection system (Bio-Rad, Hercules, CA) with specific primers. For human SPAK: sense 5' TGGAATTAGCAACAGGAGCAGCG 3', antisense 5' TTTCCAAAGTGGGTGGATCATTT 3', GAPDH acts as internal control: sense 5' ACCACAGTCCATGCCATCAC 3', antisense 5' TCCACCACCCTGTTGCTGTA 3'. For mouse SPAK: sense 5' GTAAGGCGAGTTCCTGGGTCG 3', antisense 5' CCAGTCGCCGTCTTCAGTCTT 3' 36B4 acts as internal control: sense 5' TCCAGGCTTTGGGCATCA 3', antisense 5' CTTTATCAGCTGCACATCACTCAGA.
###end p 74
###begin title 75
Nuclear protein extraction
###end title 75
###begin p 76
###xml 311 312 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 474 475 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 722 723 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Nuclear protein was extracted from Caco2-BBE cells or mucosa from mice colon tissue treated with hyperosmotic medium. Cells and mucosa were washed once in ice-cold PBS, and centrifuged at 800 rpm for 5 min. The resulting pellets were resuspended in 5 ml of cold lysis buffer (10 mM HEPES, 10 mM KC1, 1.5 mM MgC12, and 0.1% Nonidet P-40; pH 7.9 at 4degreesC) for 10 min on ice. For the isolation of nuclei, the lysate was vigorously mixed and centrifuged for 5 min at 12,000 g and 4degreesC, and the nuclear pellet was washed once with 1 ml of Nonidet P-40-free lysis buffer. For the extraction of nuclear proteins, the nuclear pellet was resuspended in 1 ml of protein extraction buffer (420 mM NaCl, 20 mM HEPES, 1.5 MgCl2, 0.2 mM EDTA, and 25% glycerol; pH 7.9) for 10 min at 4degreesC. After being vigorous mixed, the nuclear suspension was centrifuged for 5 min at 4degreesC. The protein content in the final supernatant (nuclear protein extract) was measured using the Bradford method (Bio-Rad, Hercules, CA). DTT (0.5 mM), PMSF (0.5 mM), and leupeptin (10 pg/ml) were added to the lysis and extraction buffers just before use. The diluting buffer contained the same amounts of DTT and leupeptin but only 0.2 mM PMSF. Samples were stored at -70degreesC until use.
###end p 76
###begin title 77
Transient transfection and luciferase reporter gene assay
###end title 77
###begin p 78
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 14 17 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Renilla (phRL-CMV, 5 ng) and relevant SPAK promoter constructs (4 mug) were co-transfected into Caco2-BBE cells with Lipofectin (Invitrogen, Carlsbad, CA). After stimulation, the resulting luminescence was measured for 10 s in a luminometer (Luminoskan, Thermal Labsystems, MA). Each luciferase activity was normalized based on the control Renilla luciferase activity. Extracts were analyzed in triplicate, and each experiment was performed for at least three times.
###end p 78
###begin title 79
Electrophoretic Mobility Shift Assays (EMSAs)
###end title 79
###begin p 80
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Yan2">[29]</xref>
Probes were end labeled with a Biotin 3' End DNA Labeling Kit (Pierce, Rockford, IL). Standard EMSAs and supershift EMSAs with relevant antibodies were performed using the LightShift Chemiluminescent EMSA Kit (Pierce, Rockford, IL). Probe labeling and protocol for EMSAs were as described previously [29].
###end p 80
###begin title 81
Chromatin immunoprecipitation assay
###end title 81
###begin p 82
###xml 1422 1423 1397 1398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1863 1894 1822 1853 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GTAAATGAACTTCAGGTTCTCTTTG 3&#8242;</named-content>
###xml 1904 1936 1863 1895 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CGCCCTGCGCCTTGGCCC CAGACGA 3&#8242;</named-content>
###xml 1946 1977 1905 1936 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AGCACACACAAAGCGGCCTGACTCC 3&#8242;</named-content>
###xml 1987 2018 1946 1977 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCCAGAGCCTAGCGCGCGCTGTTCT 3&#8242;</named-content>
###xml 2029 2061 1988 2020 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTGGCTTCGGCGGGGAC GGCGGCGG 3&#8242;</named-content>
###xml 2072 2105 2031 2064 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCATGATGCTGCGGAGGAGAGCAGGAG 3&#8242;</named-content>
###xml 2118 2149 2073 2104 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGCGCAGGGCGAGCAGGGAGGGAGG 3&#8242;</named-content>
###xml 2162 2194 2113 2145 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGTTCTCCGCCTCGG CGAGGGGAAC 3&#8242;</named-content>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
###xml 965 971 <span type="species:ncbi:9986">rabbit</span>
Sp1 and NF-kappaB chromatin immunoprecipitation (ChIP) assays of Caco2-BBE cells treated with hyperosmolarity (610 mOsm) for 30 min were performed using the ChIP Assay Kit (Upstate Cell Signaling Solutions, Lake Placid, NY) according to the manufacturer's instructions. Briefly, Caco2-BBE cells were fixed with 1% formaldehyde for 10 minutes at 37degreesC to initiate cross-linking, scraped off the plate, washed with ice-cold PBS, and resuspended in 200 mul of sodium dodecyl sulfate lysis buffer for 10 minutes on ice. Cells were then sonicated with three sets of 10-second pulses at 35% power to shear the DNA into 200 1,000-bp fragments. Samples were centrifuged, and the supernatant (used as total DNA input) was diluted in ChIP dilution buffer and precleared with a protein A agarose-salmon sperm DNA slurry to reduce the nonspecific background. Samples were then immunoprecipitated with 2 mug of mouse anti-Sp1 (Upstate Cell Signaling Solutions) or 3 mug of rabbit anti-p65 antibody (Santa Cruz Biotechnology) overnight at 4degreesC. Complexes were collected in a protein A agarose-salmon sperm DNA slurry for 1 hour at 4degreesC, washed once each with the provided low-salt, high-salt, and LiCl wash buffers, and then washed twice in Tris-EDTA buffer [10 mmol/L Tris-HCl (pH 8.0) and 1 mmol/L EDTA]. The immunoprecipitated chromatin was eluted from protein A using freshly prepared elution buffer (100 mmol/L NaHCO3 and 1% sodium dodecyl sulfate), and the protein-DNA cross-links were reversed by treatment with NaCl (200 mmol/L) at 65degreesC for 4 hours. The DNA was purified by incubation with proteinase K at 45degreesC for 1 hour, followed by phenol-chloroform extraction and ethanol precipitation with glycogen. Sp1 (I, II, and III) and NF-kappaB binding sites in immunoprecipitates were detected by PCR using the following specific primers: Sp1 IF 5' GTAAATGAACTTCAGGTTCTCTTTG 3', Sp1 IR: 5' CGCCCTGCGCCTTGGCCC CAGACGA 3'; Sp1 IIF 5' AGCACACACAAAGCGGCCTGACTCC 3', Sp1 IIR 5' CCCAGAGCCTAGCGCGCGCTGTTCT 3'; Sp1 IIIF 5' CTGGCTTCGGCGGGGAC GGCGGCGG 3'; Sp1 IIIR 5' CCATGATGCTGCGGAGGAGAGCAGGAG 3'; NF-kappaBF 5' GGCGCAGGGCGAGCAGGGAGGGAGG 3', NF-kappaBR 5' TGTTCTCCGCCTCGG CGAGGGGAAC 3'. The products were resolved on a 1% agarose gel and visualized with ethidium bromide.
###end p 82
###begin title 83
Transfection of siRNA
###end title 83
###begin p 84
Subconfluent (60%) Caco2-BBE cells plated on six-well plates (Costar, Corning, NY) were transfected with siRNA duplexes directed against Sp1 and NF-kappaB, and a non targeting siRNA was used as the control for non-sequence-specific effects of siRNAs (Ambion, Austin, TX) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in serum-free medium. Serum was added after 24 h, Caco2-BBE cells underwent hyperosmolarity treatment (610 mOsm) for 30 min; cells were then collected for western blot analysis with relevant antibodies.
###end p 84
###begin title 85
Nuclear run-on assay
###end title 85
###begin p 86
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Gnoni1">[94]</xref>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 762 763 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 776 777 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 928 936 924 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Nuclear run-on assay was performed following the previous protocol [94] with little modification. Briefly; nuclei were isolated from Caco2-BBE cells treated with or without hyperosmolarity for 1 hour. Around 5x107 cells were pelleted then lysed on ice for 10 min in lysis buffer containing 0.3 M sucrose, 0.4% (v/v) NP-40, 10 mM Tris-HCl at pH 7.4, 10 mM NaCl, and 3 mM MgCl2. After centrifugation (15 min at 500 relative centrifuge force), the nuclear pellet was resuspended and subjected to a repeat (5 min) lysis to remove any remaining intact cells. Following centrifugation, nuclei were purified by centrifugation through a 2.0 M sucrose cushion. The nuclei were resuspended in 300 mul of transcription buffer (50 mM Tris-HCl [pH 8.0], 150 mM KCl, 5 mM MgCl2, 0.5 mM MnCl2, 1 mM dithiothreitol, 0.1 mM EDTA, 10% glycerol). After pretreatment with 1 mul of 50 mug/ml RNase A and followed by 2.5 mul of 100 units RNasin, the in vitro elongation reaction was initiated with the addition of ribonucleotides to a final concentration of 0.25 mM each ATP, GTP, CTP and UTP. The reaction was carried out for 25 min at 30degreesC. After incubation with RNase-free DNase, RNA was extracted with phenol-chloroform, precipitated with ammonium acetate and isopropanol, washed with 70% ethanol, and dissolved in water. cDNA was synthesized with The SuperScript(R) III First-Strand Synthesis System (Invitrogen, Carlsbad, CA) and amplified with Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) using SPAK HQF and SPAK HQR as primers. GAPDH acts as internal control. The products were resolved on a 1.5% agarose gel and visualized with ethidium bromide.
###end p 86
###begin title 87
SPAK mRNA stability assay and northern blot
###end title 87
###begin p 88
###xml 297 326 296 325 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGGAATTAGCAACAGGAGCAGCG 3&#8242;</named-content>
###xml 340 369 339 368 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TTTCCAAAGTGGGTGGATCATTT 3&#8242;</named-content>
###xml 452 483 451 482 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCCCTCGATGCTCTTAGCTGAGTGT 3&#8242;</named-content>
###xml 494 524 493 523 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CGCCGGTCCAAGAATTTCACCTCT 3&#8242;</named-content>
###xml 606 610 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Nwagwu1">[95]</xref>
###xml 974 1003 973 1002 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTGATTGAGAAGCTGCTTACAAG 3&#8242;</named-content>
###xml 1019 1048 1018 1047 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CAAGAAGAAGCTTCTCTGTAGTC 3&#8242;</named-content>
For mRNA decay experiments, Caco2-BBE cells pretreated with actinomycin D (5 mug/ml) for 1 hour to arrest transcription were cultured in hyperosmotic medium (610 mOsm) or isoosmotic DMEM at indicated time points. The decay of SPAK mRNA was examined by real time PCR with specific primers SPAKHQF: 5' TGGAATTAGCAACAGGAGCAGCG 3' and SPAKHQR: 5' TTTCCAAAGTGGGTGGATCATTT 3'. Levels of mRNA were then standardized against 18s rRNA levels with primers 18SF: 5' CCCCTCGATGCTCTTAGCTGAGTGT 3' and 18SR: 5' CGCCGGTCCAAGAATTTCACCTCT 3', taking into account a previous determination of 65 hours for 18s rRNA half life [95], and plotted as the percentage of remaining mRNA compared to message levels at the 0 time point (where there is a 100% maximum mRNA level). The 1-hour time point sample was also used for Northern blot analysis with the North2South complete biotin random prime labeling and detection kit (Pierce, Rockford, IL) with probe generated by PCR with primers: SPAKNorFor 5' CTGATTGAGAAGCTGCTTACAAG 3' and SPAKNorRev 5' CAAGAAGAAGCTTCTCTGTAGTC 3'.
###end p 88
###begin title 89
Permeability assay
###end title 89
###begin p 90
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Furuta1">[96]</xref>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005049-Garg1">[97]</xref>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vito</italic>
###xml 660 661 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1081 1088 1064 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1137 1152 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
In vitro and in vivo permeability assays to determine barrier function were performed using the FITC-Dextran method as described previously [96], [97]. For in vito permeability assays, Caco2-BBE cells transfected with SPAK/pcDNA6, vector pcDNA6, SPAK siRNA (Ambion, Austin, TX) and con siRNA (same sequence with random order) were plated on transwell filters (Costar, Corning, New York) to grow to just confluency. For permeability assays, 100 mul of conditioned medium with FITC-Dextran (10 mg/ml, MW 4 kDa; Sigma-Aldrich, ST. Louis, MO) are added into the upper chamber of the transwell chamber, the plate is incubated at 37degreesC in an atmosphere of 5% CO2. Samples are taken from the lower chamber with/without treatment of hyperosmolarity (610 mOsm) for 30 min. The permeability of the epithelial monolayer correlates with the fluorescence intensity in the lower chamber (lambda ex = 492 nm, lambda em = 510 nm; Cytofluor 2300; Millipore, Waters Chromatography). Values are shown as nanograms per milliliter per minute FITC-dextran present in the basolateral reservoir. For in vivo permeability assay, 8-wk old wild type and SPAK transgenic mice were used. Food and water were withdrawn for 4 h and mice were gavaged with permeability tracer FITC-labeled dextran (60 mg/100 g body weight MW 4 kDa; Sigma-Aldrich, ST. Louis, MO). Serum was collected retro-orbitally 4 h after gavage; fluorescence intensity of each sample was measured (lambda ex = 492 nm, lambda em = 510 nm; Cytofluor 2300; Millipore, Waters Chromatography); and FITC-dextran concentrations were determined from standard curves generated by serial dilution of FITC-dextran and represented as mug FITC-dextran/mug protein.
###end p 90
###begin title 91
Supporting Information
###end title 91
###begin p 92
(0.65 MB DOC)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
(0.03 MB DOC)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
(0.27 MB DOC)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin title 98
References
###end title 98
###begin article-title 99
Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis.
###end article-title 99
###begin article-title 100
###xml 27 35 <span type="species:ncbi:9606">patients</span>
Intestinal permeability in patients with Crohn's disease and their healthy relatives.
###end article-title 100
###begin article-title 101
###xml 63 68 <span type="species:ncbi:9606">human</span>
Cellular basis for defective electrolyte transport in inflamed human colon.
###end article-title 101
###begin article-title 102
Organic anions and the diarrhea of inflammatory bowel disease.
###end article-title 102
###begin article-title 103
Neonatal necrotizing enterocolitis. Inflammatory bowel disease of the newborn.
###end article-title 103
###begin article-title 104
###xml 81 86 <span type="species:ncbi:9606">human</span>
Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells.
###end article-title 104
###begin article-title 105
Hyperosmotic stress as a stimulant for proinflammatory cytokine production.
###end article-title 105
###begin article-title 106
###xml 52 57 <span type="species:ncbi:9606">human</span>
Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase.
###end article-title 106
###begin article-title 107
###xml 96 101 <span type="species:ncbi:9606">human</span>
Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells.
###end article-title 107
###begin article-title 108
###xml 93 98 <span type="species:ncbi:9606">human</span>
Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells.
###end article-title 108
###begin article-title 109
###xml 86 91 <span type="species:ncbi:9606">human</span>
High glucose and hyperosmolarity increase secretion of interleukin-1 beta in cultured human aortic endothelial cells.
###end article-title 109
###begin article-title 110
Osmotic stress, a proinflammatory signal in Caco-2 cells.
###end article-title 110
###begin article-title 111
###xml 107 112 <span type="species:ncbi:9606">human</span>
JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells.
###end article-title 111
###begin article-title 112
Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity.
###end article-title 112
###begin article-title 113
Hyperosmolarity causes inflammation through the methylation of protein phosphatase 2A.
###end article-title 113
###begin article-title 114
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface.
###end article-title 114
###begin article-title 115
###xml 13 19 <span type="species:ncbi:9986">rabbit</span>
A convenient rabbit model of ocular epithelium damage induced by osmotic dehydration.
###end article-title 115
###begin article-title 116
Pak to the future.
###end article-title 116
###begin article-title 117
Signaling by the germinal center kinase family of protein kinases.
###end article-title 117
###begin article-title 118
###xml 77 82 <span type="species:ncbi:4932">yeast</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.
###end article-title 118
###begin article-title 119
Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development.
###end article-title 119
###begin article-title 120
###xml 37 42 <span type="species:ncbi:4932">yeast</span>
Integrative model of the response of yeast to osmotic shock.
###end article-title 120
###begin article-title 121
Deficiency of a STE20/PAK family kinase LOK leads to the acceleration of LFA-1 clustering and cell adhesion of activated lymphocytes.
###end article-title 121
###begin article-title 122
Association of the Ste20-like kinase (SLK) with the microtubule. Role in Rac1-mediated regulation of actin dynamics during cell adhesion and spreading.
###end article-title 122
###begin article-title 123
p21-activated kinase regulates endothelial permeability through modulation of contractility.
###end article-title 123
###begin article-title 124
Induction of vascular permeability: beta PIX and GIT1 scaffold the activation of extracellular signal-regulated kinase by PAK.
###end article-title 124
###begin article-title 125
SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.
###end article-title 125
###begin article-title 126
Cloning and characterization of a new intestinal inflammation-associated colonic epithelial Ste20-related protein kinase isoform.
###end article-title 126
###begin article-title 127
Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation.
###end article-title 127
###begin article-title 128
The Ste20 group kinases as regulators of MAP kinase cascades.
###end article-title 128
###begin article-title 129
SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway.
###end article-title 129
###begin article-title 130
Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).
###end article-title 130
###begin article-title 131
PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1).
###end article-title 131
###begin article-title 132
Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.
###end article-title 132
###begin article-title 133
Expression of the bumetanide-sensitive Na-K-Cl cotransporter BSC2 is differentially regulated by fluid mechanical and inflammatory cytokine stimuli in vascular endothelium.
###end article-title 133
###begin article-title 134
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking NKCC1 are protected from development of bacteremia and hypothermic sepsis secondary to bacterial pneumonia.
###end article-title 134
###begin article-title 135
Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters.
###end article-title 135
###begin article-title 136
Changes in cytoskeletal actin content, F-actin distribution, and surface morphology during HL-60 cell volume regulation.
###end article-title 136
###begin article-title 137
Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling.
###end article-title 137
###begin article-title 138
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines.
###end article-title 138
###begin article-title 139
###xml 90 114 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cloning and characterization of seven cDNAs for hyperosmolarity-responsive (HOR) genes of Saccharomyces cerevisiae.
###end article-title 139
###begin article-title 140
Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and muller cells.
###end article-title 140
###begin article-title 141
Modulation of CFTR gene expression in HT-29 cells by extracellular hyperosmolarity.
###end article-title 141
###begin article-title 142
Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.
###end article-title 142
###begin article-title 143
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Developmental expression of Sp1 in the mouse.
###end article-title 143
###begin article-title 144
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
###end article-title 144
###begin article-title 145
Signaling to NF-kappaB.
###end article-title 145
###begin article-title 146
Circuitry of nuclear factor kappaB signaling.
###end article-title 146
###begin article-title 147
NF-kappa B subunit-specific regulation of the interleukin-8 promoter.
###end article-title 147
###begin article-title 148
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
###end article-title 148
###begin article-title 149
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.
###end article-title 149
###begin article-title 150
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.
###end article-title 150
###begin article-title 151
Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.
###end article-title 151
###begin article-title 152
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
###end article-title 152
###begin article-title 153
###xml 4 21 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
###end article-title 153
###begin article-title 154
Transcriptional activation by NF-kappaB requires multiple coactivators.
###end article-title 154
###begin article-title 155
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.
###end article-title 155
###begin article-title 156
Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells.
###end article-title 156
###begin article-title 157
Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1.
###end article-title 157
###begin article-title 158
###xml 18 23 <span type="species:ncbi:9606">human</span>
Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors.
###end article-title 158
###begin article-title 159
Functional interference of Sp1 and NF-kappaB through the same DNA binding site.
###end article-title 159
###begin article-title 160
Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes.
###end article-title 160
###begin article-title 161
Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells.
###end article-title 161
###begin article-title 162
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.
###end article-title 162
###begin article-title 163
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
###end article-title 163
###begin article-title 164
The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction.
###end article-title 164
###begin article-title 165
Inhibition of NF-kappa B by sodium salicylate and aspirin.
###end article-title 165
###begin article-title 166
###xml 47 57 <span type="species:ncbi:7227">Drosophila</span>
Post-transcriptional regulation contributes to Drosophila clock gene mRNA cycling.
###end article-title 166
###begin article-title 167
Both Erk and p38 kinases are necessary for cytokine gene transcription.
###end article-title 167
###begin article-title 168
Osmoregulation by slow changes in aldose reductase and rapid changes in sorbitol flux.
###end article-title 168
###begin article-title 169
Osmotic regulation of aldose reductase protein synthesis in renal medullary cells.
###end article-title 169
###begin article-title 170
###xml 79 84 <span type="species:ncbi:9940">sheep</span>
Luminal hyperosmolarity decreases Na transport and impairs barrier function of sheep rumen epithelium.
###end article-title 170
###begin article-title 171
Hyperosmolarity enhances the lung capillary barrier.
###end article-title 171
###begin article-title 172
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
###end article-title 172
###begin article-title 173
###xml 37 42 <span type="species:ncbi:9606">human</span>
Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways.
###end article-title 173
###begin article-title 174
Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.
###end article-title 174
###begin article-title 175
###xml 12 17 <span type="species:ncbi:9606">human</span>
Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis.
###end article-title 175
###begin article-title 176
Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.
###end article-title 176
###begin article-title 177
Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions.
###end article-title 177
###begin article-title 178
Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol.
###end article-title 178
###begin article-title 179
###xml 136 160 <span type="species:ncbi:83334">Escherichia coli O157:H7</span>
Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
###end article-title 179
###begin article-title 180
Cytoskeletal regulation of pulmonary vascular permeability.
###end article-title 180
###begin article-title 181
Role of endothelial cell cytoskeleton in control of endothelial permeability.
###end article-title 181
###begin article-title 182
Contribution of F-actin to barrier properties of the blood-joint pathway.
###end article-title 182
###begin article-title 183
###xml 84 89 <span type="species:ncbi:9606">human</span>
Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells.
###end article-title 183
###begin article-title 184
Focal adhesion kinase controls pH-dependent epidermal barrier homeostasis by regulating actin-directed Na+/H+ exchanger 1 plasma membrane localization.
###end article-title 184
###begin article-title 185
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
###end article-title 185
###begin article-title 186
Review article: the aetiopathogenesis of inflammatory bowel disease-immunology and repair mechanisms.
###end article-title 186
###begin article-title 187
A porous defense: the leaky epithelial barrier in intestinal disease.
###end article-title 187
###begin article-title 188
p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
###end article-title 188
###begin article-title 189
Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
###end article-title 189
###begin article-title 190
Mechanism of initiator-mediated transcription: evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition sequence.
###end article-title 190
###begin article-title 191
###xml 66 71 <span type="species:ncbi:9606">human</span>
Sp1 is a critical factor for the monocytic specific expression of human CD14.
###end article-title 191
###begin article-title 192
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Short-term stimulation of lipogenesis by triiodothyronine in maintenance cultures of rat hepatocytes.
###end article-title 192
###begin article-title 193
###xml 40 45 <span type="species:ncbi:9031">chick</span>
Ribonucleic acid synthesis in embryonic chick muscle, rates of synthesis and half-lives of transfer and ribosomal RNA species.
###end article-title 193
###begin article-title 194
Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.
###end article-title 194
###begin article-title 195
Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.
###end article-title 195
###begin p 196
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 196
###begin p 197
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institutes of Health of Diabetes and Digestive and Kidney Diseases by grants R24-DK-064399 (center grant), RO1-DK-061941 (to D. Merlin), RO1-DK55850 (S. Sitaraman). Y. Yan is a recipient of a research fellowship award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 197

